Epilepsy Drugs Market Growth, Trends, Analysis and Forecast

Market Reports Center
One Stop Market Reaserch Shop
Epilepsy Drugs Market Share, Size, Global Insights,
Emerging Trends, Growth Drivers and Future Outlook:
Market Reports Center
Technavio Announces the Publication of its Research Report – Global Epilepsy Drugs Market 2016-2020
Technavio recognizes the following companies as the key players in the global epilepsy drugs market:
Eisai, GSK, Pfizer, and UCB.
Other Prominent Vendors in the market are: Acorda Therapeutics, Alexza Pharmaceuticals, Aprecia
Pharmaceuticals, Aurobindo Pharma, Biscayne Pharmaceuticals, CURx Pharmaceuticals, Dainippon
Sumitomo Pharma, D-Pharm, F. Hoffmann-La Roche, Grupo Ferrer Internacional, GW Pharmaceuticals,
Insero Health, INSYS Therapeutics, Janssen Pharmaceuticals, Ligand Pharmaceuticals, H. Lundbeck,
MarcoPolo Pharmaceuticals, Marinus Pharmaceuticals, Meda, Neurelis, Nobelpharma, Novartis,
Orphelia Pharma, SAGE Therapeutics, SciFlour, Sedpr Pharmaceuticals, Shire, SK Biopharmaceuticals,
Sun Pharmaceutical, Sunovion Pharmaceuticals (US), Supernus Pharmaceuticals, Takeda, Turing
Pharmaceuticals, Upsher-Smith, Valeant Pharmaceuticals, and Zogenix.
Browse Detail Report With TOC @
Commenting on the report, an analyst from Technavio’ s team said: “A trend which will boost market
growth is the reformulation of marketed drugs. Drug delivery systems such as dispersible and filmcoated tablets increase the efficacy of medicines either by increasing the bioavailability of the drug or by
expanding patient compliance. This reformulation results in products with improved safety and efficacy
profiles and provides an opportunity for drug manufacturers to extend the term of their drug's patents,
delaying the market entry of generics. For instance, UCB, Pfizer, and GSK developed film-coated tablets
Market Reports Center
One Stop Market Reaserch Shop
of Keppra, Neurontin, and Trobalt, respectively. Film-coated tablets offer specific properties such as
taste-masking, moisture and light protection, superior product appearance, and mechanical resistance.”
According to the report, a key growth driver is the tentative approval of late-stage pipeline molecules.
Though a number of branded and generic drugs are available in the market to treat epilepsy, they
provide only symptomatic treatment. Hence, the need for effective medications still prevails in the
market. This has increased investment in the R&D of new drugs for epilepsy by companies such as
Marinus Pharmaceuticals, SAGE Therapeutics, H. Lundbeck, and CURx Pharmaceuticals. Drugs in the
regulatory filing and Phase III stages are expected to enter the market during the forecast period.
Further, the report states that one challenge that could hamper market growth is the social stigma
associated with epilepsy.
The study was conducted using an objective combination of primary and secondary information
including inputs from key participants in the industry. The report contains a comprehensive market and
vendor landscape in addition to a SWOT analysis of the key vendors.
About the Epilepsy Drugs Market
Epilepsy is characterized by recurrent seizures caused by the improper balance between inhibitory and
excitatory signals in the brain. The symptoms of epilepsy, caused by brain malformations and tumors,
birth trauma, and high-risk pregnancies, can be benign or life-threatening. A majority of epilepsy cases
have an unknown etiology.
Etiology varies according to the age of a person. Some individuals genetically inherit the disease while
the cause of the disease in others is unknown. Head injuries, tumors, autism spectrum disorder, or
stroke can also cause the disorder.
Technavio’ s analysts forecast the global epilepsy drugs market to grow at a CAGR of 4.45% during the
period 2016-2020.
Covered in this report
The report covers the present scenario and the growth prospects of the global epilepsy drugs market for
2016-2020. To calculate the market size, the report considers revenue generated from the sales of
branded and generic drugs used to treat and prevent epilepsy and related seizures. The report also
considers the revenues to be generated from the sales of drugs that are expected to be launched into
the market along with the decline in revenues from the patent expiries of marketed drugs during the
forecast period.
The market is divided into the following segments based on geography:
• Americas
Market Reports Center
One Stop Market Reaserch Shop
Technavio's report, Global Epilepsy Drugs Market 2016-2020, has been prepared based on an in-depth
market analysis with inputs from industry experts. The report covers the market landscape and its
growth prospects over the coming years. The report also includes a discussion of the key vendors
operating in this market.
Key vendors
• Eisai
• Pfizer
Other prominent vendors
• AbbVie
• Acorda Therapeutics
• Alexza Pharmaceuticals
• Aprecia Pharmaceuticals
• Aurobindo Pharma
• Biscayne Pharmaceuticals
• CURx Pharmaceuticals
• Dainippon Sumitomo Pharma
• D-Pharm
• F. Hoffmann-La Roche
• Grupo Ferrer Internacional
• GW Pharmaceuticals
• Insero Health
• INSYS Therapeutics
• Janssen Pharmaceuticals
• Ligand Pharmaceuticals
• H. Lundbeck
• MarcoPolo Pharmaceuticals
• Marinus Pharmaceuticals
• Meda
• Neurelis
• Nobelpharma
• Novartis
• Orphelia Pharma
• SAGE Therapeutics
• SciFlour
• Sedor Pharmaceuticals
• Shire
• SK Biopharmaceuticals
• Sun Pharmaceutical
• Sunovion Pharmaceuticals (US)
Market Reports Center
One Stop Market Reaserch Shop
• Supernus Pharmaceuticals
• Takeda
• Turing Pharmaceuticals
• Upsher-Smith
• Valeant Pharmaceutical
• Zogenix
Market driver
• Tentative approval of late-stage pipeline molecules
• For a full, detailed list, view our report
Market challenge
• Social stigma associated with epilepsy
• For a full, detailed list, view our report
Market trend
• Reformulation of marketed drugs
• For a full, detailed list, view our report
Key questions answered in this report
• What will the market size be in 2020 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?
You can request one free hour of our analyst’ s time when you purchase this market report. Details are
provided within the report.
Request A Sample copy of This Report @ https://marketreportscenter.com/request-sample/319887
Table of Content
PART 01: Executive summary
• Highlights
PART 02: Scope of the report
• Market overview
• Top-vendor offerings
PART 03: Market research methodology
• Research methodology
• Economic indicators
PART 04: Introduction
• Key market highlights
Market Reports Center
One Stop Market Reaserch Shop
• Epilepsy: An overview
PART 05: Pipeline analysis
PART 06: Key buying criteria for anti-epileptic drugs
PART 07: Market landscape
• Market overview
• Five forces analysis
PART 08: Market segmentation by generation of drugs
• First-generation anti-epileptic drugs
• Second-generation anti-epileptic drugs
• Third-generation anti-epileptic drugs
PART 09: Market segmentation by spectrum of activity
• Narrow-spectrum anti-epileptic drugs
• Broad-spectrum anti-epileptic drugs
PART 10: Market segmentation by type of seizures
To Get Discount On The Report @ https://marketreportscenter.com/request-discount/319887
About Us:
Market Reports Centeris an e-commerce platform obliging the needs of knowledge workers, experts,
professionals who are subject to market research information for their work, or to make strategic
business decisions. We are dedicated to create a comprehensive offering of market research which is
accurate, credible and affordable.
Market Reports Center currently has more than 1,20,000 plus titles and 30+ Publishers on our platform
and growing consistently. We cover more than 35 industry verticals being: Automotive, Electronics,
Manufacturing, Pharmaceuticals, Healthcare, Chemicals, Construction, Agriculture, Food, Beverages,
Banking & Finance, Media and Government, Public Sector Studies.
Contact Information:
Sam Collins
Market Reports Center
1-646-883-3044 (US)
[email protected]
Market Reports Center
One Stop Market Reaserch Shop

According to the report, a key growth driver is the tentative approval of late-stage pipeline molecules. Though a number of branded and generic drugs are available in the market to treat epilepsy, they provide only symptomatic treatment